Influence of intralipid on free propofol fraction assayed in human serum albumin solutions and human plasma

Acta Pharmacologica Sinica

Volumn 27, Issue 12, 2006, Pages 1637-1641

  Kalitynski, Rafal ^a   Dawidowicz, Andrzej L ^a   Poszytek, Jacek ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Drug binding; Human serum albumin; Intralipid; Plasma; Propofol; Unbound drugs

Indexed keywords

ALCOHOL; HUMAN SERUM ALBUMIN; INTRALIPID; PROPOFOL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; PARENTERAL NUTRITION; PLASMA; SERUM; ULTRAFILTRATION;

ANESTHETICS, INTRAVENOUS; ANTIEMETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FAT EMULSIONS, INTRAVENOUS; HUMANS; PROPOFOL; PROTEIN BINDING;

EID: 33751367515     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00454.x     Document Type: Article

References (14)

1. Mehta AC. Therapeutic monitoring of free (unbound) drug levels: analytical aspects. Trends Anal Chem 1989; 8: 107-12.
2. Paxton JW. Drug binding to plasma proteins. N Z Med J 1985; 98: 245-8.
3. Svensson CK, Woodruff MN, Baxter JG, Lalka D. Free drug concentration monitoring in clinical practice, rationale and current status. Clin Pharm 1986; 11: 450-69.
4. Olsen GD, Bennett WM, Porter GA. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther 1975; 17: 677-84.
5. Gin T. Pharmacodynamics of propofol and free drug concentrations. Anesthesiology 1993; 78: 604.
6. Vuyk J, Engbers FH, Lemmens HJ, Burm AG, Vletter AA, Gladines MP, et al. Pharmacodynamics of propofol in female patients. Anesthesiology 1992; 77: 3-9.
7. Dawidowicz AL, Kalitynski R. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid. Biomed Chromatogr 2003; 17: 447-52.
8. Dawidowicz AL, Kalitynski R, Fijalkowska A. Relationships between total and unbound propofol in plasma and CSF during continuous drug infusion. Clin Neuropharmacol 2004; 27: 129-32.
9. Dawidowicz AL, Kalitynski R. Effects of intraoperative fluid infusions, sample storage time, and sample handling on unbound propofol assay in human blood plasma. J Pharm Biomed Anal 2005; 37: 1167-71.
10. Borgeat A, Wilder-Smith OH, Suter PM. The nonhypnotic therapeutic applications of propofol. Anesthesiology 1994; 80: 642-56.
11. Dawidowicz AL, Kalitynski R, Kobielski M, Pieniadz J. Influence of propofol concentration in human plasma on free fraction of the drug. Chem Biol Interact 2006; 159: 149-55.
12. Zamacona MK, Suarez E, Garcia E, Aguirre C, Calvo R. The significance of lipoproteins in serum binding variations of propofol. Anesth Analg 1998; 87: 1147-51.
13. Plummer GF. Improved method for the determina tion of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 421: 171-6.
14. Takizawa E, Hiraoka H, Takizawa D, Goto F. Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. Br J Anaesth 2006; 96: 179-85.